p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma

Journal of Pathology

Volumn 184, Issue 4, 1998, Pages 360-368

  Cruz, Isabel B ^a,b   Snijders, Peter J F ^a   Meijer, Chris J ^a   Braakhuis, Boudewijn J ^a   Snow, Gordon B ^a   Walboomers, Jan M ^a   Van Der Waal, Isaac ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Carcinoma; Dysplasia; Immunohistochemistry; Leukoplakia; Maligna nt transformation; Oral mucosa; p53; Premalignant

Indexed keywords

PROTEIN P53;

ARTICLE; BASAL CELL; DYSPLASIA; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; MOUTH MUCOSA; PRECANCER; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031940937     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199804)184:4<360::AID-PATH1263>3.0.CO;2-H     Document Type: Article

References (35)

1. Karabulut A, Reibel J, Therkildsen MH, Praetorius F, Nielsen HW, Dabelsteen E. Observer variability in the histologic assessment of oral premalignant lesions. J Oral Pathol Med 1995; 24: 198-200.
2. Kramer IRH. Basic histopathological features of oral premalignant lesions. In: Mackenzie IC, Dabelsteen E, Squier C, eds. Oral Premalignant Lesions. Iowa: University of Iowa Press, 1980; 23-24.
3. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 1993; 53: 4477-4480.
4. Lazarus P, Garewell HS, Sciubba J, et al. A low incidence of p53 mutations in pre-malignant lesions of the oral cavity from non-tobacco users. Int J Cancer 1995; 60: 458-463.
5. Nees M, Homann N, Discher H, et al. Expression of mutated p53 occurs in tumour-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumours. Cancer Res 1993; 53: 4189-4196.
6. Bennett WP, Hollstein MC, Metcalf RA, et al. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis. Cancer Res 1992; 52: 6092-6097.
7. Chung KY, Mukhopadhyay T, Kim J, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993; 53: 1676-1683.
8. Waridel F, Estreicher A, Bron L, et al. Field cancerisation and polyclonal p53 mutation in the upper aerodigestive tract. Oncogene 1997; 14: 163-169.
9. Greenblatt MS, Bennet WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878.
10. Ahomadegbe JC, Barrois M, Fogel S, et al. High incidence of p53 alterations (mutation, deletion, overexpression) in the head and neck primary tumours and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 1995; 10: 1217-1227.
11. Burns JE, McFarlane R, Clark LJ, et al. Maintenance of identical p53 mutations throughout progression of squamous cell carcinomas of the tongue. Oral Oncol, Eur J Cancer 1994; 30B: 335-337.
12. Yang H-K, Linnoila RI, Conrad NK, et al. TP53 and ras mutations in metachronous tumours from patients with cancer of the upper aerodigestive tract. Int J Cancer (Pred Oncol) 1995; 64: 229-233.
13. Bongers V, Snow GB, Van der Waal I, Braakhuis BJM. Value of p53 expression in oral cancer and adjacent normal mucosa in relation to the occurrence of multiple primary carcinomas. Oral Oncol, Eur J Cancer 1995; 31B: 392-395.
14. Hall PA, Meek D, Lane DP. Editorial. p53 - integrating the complexity. J Pathol 1996; 180: 1-5.
15. Fritsche M, Christel H, Brandner G. Induction of nuclear accumulation of the tumour-suppressor protein p53 by DNA-damaging agents. Oncogene 1993; 8: 307-308.
16. Gujuluva CN, Baek J-H, Shin K-H, Cherrick HM, Park N-H. Effect of UV-irradiation on cell cycle, viability and the expression of p53, gadd153 and gadd45 genes in normal and HPV-immortalized human oral keratinocytes. Oncogene 1994; 9: 1819-1827.
17. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of the p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304-6311.
18. Chang F, Syrjanen S, Syrjanen K. Implications of the p53 tumour-suppressor gene in clinical oncology. J Clin Oncol 1995; 13: 1009-1022.
19. Clarke AR, Purdie CA, Harrison DJ, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849-852.
20. Lane DP. p53 and human cancers. Br Med Bull 1994; 50: 582-599.
21. Calabretta B, Kaczmarek L, Selleri L, et al. Growth-dependent expression of human Mr 53,000 tumor antigen messenger RNA in normal and neoplastic cells. Cancer Res 1986; 46: 5738-5742.
22. World Health Organizationi Collaborating Centre for Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg 1978; 46: 518-539.
23. Altman DG. Some common problems in medical research. In: Altman DG, ed. Practical Statistics for Medical Research. London: Chapman & Hall, 1995; 396-439.
24. Baas IO, Mulder JWR, Offerhaus GJA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172: 5-12.
25. Lambkin HA, Mothersill CM, Kelehan P. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. J Pathol 1994; 172: 13-18.
26. Dowel SP, Ogden GR. The use of antigen retrieval for immunohistochemical detection of p53 overexpression in malignant and benign oral mucosa: a cautionary note. J Pral Pathol Med 1996; 25: 60-64.
27. McKee PH, Hobbs C, Hall PA. Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds. Histopathology 1993; 23: 377-379.
28. Hall PA, Lane DP. Editorial. p53 in tumour pathology: can we trust immunohistochemistry? Revisited! J Pathol 1994; 172: 1-4.
29. Slootweg PJ, Koole R, Hordijk GJ. The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. Oral Oncol, Eur J Cancer 1994; 30B: 138-141.
30. Hall PA, McKee PH, Menage HP, Dover R, Lane DP. High levels of p53 protein in UV irradiated normal human skin. Oncogens 1993; 8: 203-207.
31. Lavieille JP, Brambilla E, Riva-Lavieille C, Reyt E, Charachon R, Brambilla C. Immunohistochemical detection of p53 in preneoplastic lesions and squamous cell carcinomas of the head and neck. Acta Otolaryngol (Stockholm) 1995; 115: 334-339.
32. Shin DM, Kim J, Ro JY, et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994; 54: 321-326.
33. Regezi JA, Zarbo RJ, Regev E, Pisanty S, Silverman S, Gazit D. p53 expression in sequential oral dysplasias and in situ carcinomas. J Oral Pathol Med 1995; 24: 18-22.
34. Wood MW, Medina JE, Thompson GC, Houck JR, Min K-W. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia. Otolaryngol Head Neck Surg 1994; 111: 758-763.
35. Lumerman H, Freedman P, Stanley K, et al Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995; 79: 321-329.